Reviews on Recent Clinical Trials
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 2
Author(s): Thomas P. Monath*
Affiliation:
- Acambis Inc. Cambridge, MA,United States
Export Options
About this article
Cite this article as:
Monath P. Thomas*, Meet Our Editorial Board Member, Reviews on Recent Clinical Trials 2017; 12 (2) . https://dx.doi.org/10.2174/157488711202170510202430
DOI https://dx.doi.org/10.2174/157488711202170510202430 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cellular and Biochemical Actions of Melatonin which Protect Against Free Radicals: Role in Neurodegenerative Disorders
Current Neuropharmacology Gene Therapy in the Anterior Eye Segment
Current Gene Therapy Place of Nanofiltration for Assuring Viral Safety of Biologicals
Current Nanoscience Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72
Current Immunology Reviews (Discontinued) Targeting Cytokines, Chemokines and Adhesion Molecules in Rheumatoid Arthritis
Current Rheumatology Reviews Involvement of IL-1R/TLR Signalling in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Current Molecular Medicine Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
CNS & Neurological Disorders - Drug Targets Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer
Current Pharmaceutical Design From Mice to Macaques – Animal Models of HIV Nervous System Disease
Current HIV Research Pharmaceutical Targeting of the Brain
Current Pharmaceutical Design A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease
Current Drug Targets Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer’s Disease
Recent Patents on Anti-Infective Drug Discovery Navigating Research Toward the Re-emerging Nipah Virus- A New Piece to the Puzzle
Current Pharmaceutical Design Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry Glutamate in CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition
Current Medicinal Chemistry West Nile Virus Vaccine.
Current Drug Targets - Infectious Disorders Static Cerebral Blood Flow Autoregulation in Humans
Current Hypertension Reviews Global Warming Favors Pathogenicity of the Brain-Eating Amoebae
Anti-Infective Agents The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy